Main image credit: 

in biomedical research, having the right tools can make all the difference. Mimotopes, known for their pioneering work in custom peptide synthesis, now brings their expertise to the forefront of antibody production. Whether you're in need of specific antibodies for immunoassays or robust screening services, Mimotopes has the solutions you require.

Mimotopes specializes in generating high-quality polyclonal antibodies, streamlining the development process that typically accompanies monoclonal antibodies. This approach not only saves time but also ensures reliable and effective reagents for your research.

One of the highlights of Mimotopes' offerings is their proficiency in designing and producing affinity-purified rabbit anti-peptide antibodies. These antibodies are essential in applications like the Sandwich ELISA, where specificity and sensitivity are paramount. With typical detection sensitivity in the low ng/mL range, Mimotopes' antibodies provide the precision needed for accurate and dependable results.

Standard Rabbit Package Deliverables

• All Polyclonal packages come with a QA report which includes HPLC and MS trace for peptides, a conjugate report and an ELISA data sheet
• All anti-peptide packages come with an ELISA guarantee >1:50,000
• Protein packages have DOT BLOT confirmation
• Standard packages have a 63-day immunization protocol; this may be extended to achieve guaranteed titres
• Express or customized protocols can be utilized upon request

From serum purification to peptide conjugation, Mimotopes offers a complete suite of products and services tailored to your immunization and antibody needs: 

Affinity Support Products: Purify your serum to obtain specific antibodies with ease.
​​​​​​​High-Quality Peptides: Mimotopes provides purified peptides conjugated to immunogenic protein carriers, such as Keyhole Limpet Hemocyanin (KLH), Bovine Serum Albumin (BSA), or Ovalbumin.

Mimotopes' flexibility allows for both standard and customized polyclonal packages, ensuring that your unique requirements are met. They offer a range of options from basic serum antibody packages to more complex peptide packages that include affinity-purified antibodies.

Mimotopes doesn't stop at antibody production. They also provide expert assay development and screening services, including:

Epitope Mapping: Identify specific regions on proteins that antibodies can target. 
Competition ELISA: Evaluate the binding affinity of your antibodies. 
Assay Development: Tailor assays specific to your research needs.

Additionally, Mimotopes' PepSet™ libraries are invaluable for T-cell mapping, helping researchers gain deeper insights into immune responses.

With a legacy of innovation and quality, Mimotopes continues to push the boundaries of what's possible in peptide and antibody technology. Their comprehensive range of products and services, backed by rigorous quality assurance protocols, ensures that researchers have the tools they need to advance their work confidently.

Mimotopes is ready to assist with designing and coordinating antibody production specific to your protein of interest. With offices and support available worldwide, they are equipped to meet the demands of the global research community.

Stay tuned for our newest offering: Camelid nanobodies, which are derived from llamas, alpacas, and camels, and provide unique immune responses.

For more information or to get started with your custom antibody project, contact Mimotopes today. 

Main image credit: 

Healthcare is evolving rapidly, largely driven by the growing demand for personalized care. The industry is shifting toward tailoring treatments based on each patient's genetic makeup and lifestyle, and tools that allow capturing, analyzing, and sharing vast amounts of patient data are becoming essential. openEHR, an open-source standard for electronic health records (EHRs), is exactly that kind of tool. As an enabler of interoperability and data-driven innovation, openEHR provides the foundation for advancing personalized medicine and improving patient engagement.

openEHR is a structured, framework that empowers healthcare providers to make smarter decisions, engage patients more effectively, and improve outcomes. This article explores how exactly openEHR supports personalized medicine and better care. It will be of particular interest to healthcare IT decision-makers, healthcare administrators, clinicians interested in digital health innovations, and executives at health tech companies, especially those developing EHR applications.

openEHR offers a flexible, interoperable, patient-centered approach to EHRs. Designed to capture complex clinical information, it enables informed decisions. Its key elements include: 

Archetypes and templates 
openEHR uses archetypes - blueprints defining the structure and meaning of clinical data - to ensure consistency across systems. Templates are context-specific versions of archetypes, enabling customization while maintaining standardized data. 

Interoperability and data standardization 
A core strength of openEHR is its commitment to interoperability. By adhering to open standards, openEHR enables seamless data exchange across systems, reducing information silos and fostering collaborative care. 

Capturing rich clinical data 
openEHR captures a broad range of clinical data, including patient history, medications, allergies, vital signs, and clinical observations. This comprehensive data enables healthcare providers to make informed, evidence-based decisions.

The goal of personalized medicine is to tailor treatment to individuals based on their unique medical history. As a flexible infrastructure for managing detailed clinical data, openEHR significantly aids medical professionals in achieving this goal. Here’s what we mean: 

Comprehensive data capture. openEHR standardizes the capture and storage of diverse patient data, including genetic, lifestyle, and environmental factors, making it easy to search, analyze, and share. This helps identify trends for personalized treatment plans. 

Enable precision medicine. By organizing patient data, openEHR enables the identification of patterns that inform personalized treatment, such as determining patients at high risk for certain diseases or those likely to respond well to specific medications. 

Facilitate decision support. openEHR enhances clinical decision-making by providing quick access to patient data and clinical guidelines, helping clinicians make informed choices about diagnosis, treatment, and care planning. 

When patients have access to their electronic health records, they can take a more active role in managing their health. Research has definitively shown that EHR access provides reassurance, reduces anxiety, improves consultations, enhances doctor-patient relationships, increases medication awareness and adherence, and ultimately improves patient outcomes. In addition, patient access to health information has been found to improve self-reported levels of engagement or activation related to self-management, enhance knowledge, and boost recovery scores. Through openEHR, patients can benefit from this access via: 

Patient portals. These secure online platforms allow patients to view their health records, schedule appointments, and communicate with healthcare providers. When integrated with openEHR, patient portals offer real-time, accurate data that increases patient awareness and encourages adherence to treatment plans. This capability fosters a stronger doctor-patient relationship, reduces patient anxiety, and positively impacts consultations, all of which contribute to improved self-management and recovery. 

Mobile health apps. Mobile apps powered by openEHR data offer personalized and up-to-date health insights. Patients can use these apps to track health metrics, set medication reminders, and receive tailored recommendations. Access to real-time data can boost patient engagement and activation, leading to higher levels of self-management, improved health knowledge, and better adherence to care plans. For instance, mobile apps that leverage openEHR data can assist in managing chronic conditions by providing patients with tools to closely monitor key indicators, ultimately improving health outcomes.

Research definitively validates openEHR’s value in personalized medicine and care improvement. In this study, for example, the researchers are using openEHR archetypes structured genomic data in a reusable, machine-readable format, facilitating the tracking of resources and tools in genomic research. This model demonstrates openEHR’s capacity for integrating genetic data into clinical care, enhancing precision in diagnosis and treatment. 

According to this research on the openEHR approach, it enhances interoperability between EHR systems by using a two-level modeling structure: the reference model (RM) for data organization and the archetype model (AM) for domain-specific knowledge representation. This enables seamless data exchange and semantic interoperability across diverse healthcare platforms, ensuring accurate data sharing between providers. The use of reusable archetypes allows for customization to meet local needs while reducing development effort, and legacy EHR data can be easily integrated into modern systems. 

Additionally, the study highlights that openEHR supports scalability, making it suitable for large-scale healthcare implementations. Its open standard ensures long-term sustainability, as the system is regularly updated by a global community, allowing it to adapt to evolving healthcare needs and regulations. This approach provides a robust, future-proof solution that ensures interoperability and integration, promoting efficient and accurate data management across healthcare organizations. 

According to a study published in Procedia Computer Science, the quality and safety of clinical decisions depend heavily on the information acquired from the records maintained by health professionals. Traditional Electronic Health Records EHR systems, while useful for storing and reusing clinical records, have proven insufficient for supporting advanced clinical decision-making. To address this, the paper highlights the adoption of the OpenEHR standard, which emphasizes semantic interoperability and the use of open models to facilitate better communication and knowledge sharing between heterogeneous systems in healthcare facilities.  

This adoption promotes the use of structured clinical knowledge and improves the decision-making process by ensuring that data exchange between systems is efficient and accurate. The research was conducted at the Centro Hospitalar Universitário do Porto (CHUP) in Portugal, where the OpenEHR approach was implemented to enhance interoperability and standardize clinical decision support. The study underscores the potential of OpenEHR in creating a more effective and safer healthcare environment by allowing for the seamless integration of data from different systems while preserving the meaning intended by the author of each clinical record.

openEHR has the potential to transform healthcare by providing a robust, flexible framework for managing clinical data. By empowering providers to make informed decisions and engage patients, openEHR drives advancements in personalized medicine, population health, and patient safety. Embracing open standards and interoperability, openEHR paves the way for a patient-centered, data-driven healthcare future. 

If you’d like to learn more about the transformative power of openEHR, download Avenga and Qinshift’s free whitepaper, Healthcare Reimagined: The Transformative Power of openEHR in eHealth, where we discuss how our organization empowers providers with data-centric solutions, reshaping data architecture and driving innovation in eHealth.